Virtual elimination of necrotising enterocolitis for 5 years - Reasons?

Medical Hypotheses

Volumn 61, Issue 5-6, 2003, Pages 617-622

  Patole, S ^a,b   McGlone, L ^a   Muller, R ^b  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYMETHYLCELLULOSE; ERYTHROMYCIN; INDOMETACIN; LAXATIVE; PROKINETIC AGENT;

ARTICLE; BREAST MILK; CLINICAL TRIAL; ENTERIC FEEDING; FEMALE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MILK; NECROTIZING ENTEROCOLITIS; NEWBORN; PRIORITY JOURNAL; SEPSIS;

EID: 0242551004     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00251-2     Document Type: Article

References (51)

1. Patole S. K., Almonte R., Kadalraja R., Tuladhar R., Muller R., Whitehall J. S. Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates? IJCP 2000; 54: 504-508.
2. Patole, SK, Muller R. Does carboxymethylcellulose have a role in reducing time to full feeds in preterm neonates? In Proceedings of the Perinatal Society of Australia and New Zealand (PSANZ) 7th Annual Congress; March 2003. p. 156.
3. Patole S. K., Kadalraja R., Tuladhar R., Almonte R., Muller R., Whitehall J. S. Benefits of a standardised feeding regimen during a clinical trial in preterm neonates. IJCP 2000; 54: 429-431.
4. Kadalraja R., Patole S. K., Muller R., Whitehall J. S. Comparison of clinical characteristics and high-risk factors in Australian aboriginal and non-aboriginal neonates with necrotising enterocolitis. IJCP 2001; 55: 251-254.
5. Lantos J. D. The "inclusion benefit" in clinical trials. J Pediatr 1999; 134: 130-137.
6. Patole SK, Muller R. Enteral feeding of preterm neonates - a survey of australian neonatologists. In Proceedings of the Perinatal Society of Australia and New Zealand (PSANZ) 7th Annual Congress; March 2003. p. 155.
7. Kosloske A. M. The epidemiology and pathogenesis of necrotising enterocolitis. Semin Neonatol 1997; 2: 231-238.
8. Ewer A. K. Role of platelet-activating factor in the pathophysiology of necrotising enterocolitis. Acta Paediatr Suppl 2002; 437: 2-5.
9. Ziegler E. E., Thureen P. J., Carlson S. J. Aggressive nutrition of the very low birth weight infant. Clin Perinatol 2002; 29 225-244.
10. Thureen P. J., Hay W. W., Jr Early aggressive nutrition in preterm infants. Semin Neonatol 2001; 6: 405-415.
11. Van Bel F., Van Zoeren D., Schipper J., Guit G. L., Baan J. Effect of indomethacin on superior mesenteric artery blood flow velocity in preterm infants. J Pediatr 1990; 116: 965-970.
12. Coombs R. C., Morgan M. E., Durbin G. M., Booth I. W., McNeish A. S. Doppler assessment of human neonatal gut blood flow velocities: postnatal adaptation and response to feeds. J Paediatr Gastroenterol Nutr 1992; 15: 6-12.
13. Evans N., Moorecraft J. Effect of patency of the ductus arteriosus on blood pressure in very preterm infants. Arch Dis Child 1992; 67: 1169-1173.
14. Sileri P., Sica G. S., Rastellini C. et al. Bacterial translocation and its surgical implications. G Chir 1999; 20: 440-444.
15. Sam II A. D., Sharma A. C., Law W. R., Ferguson J. L. Splanchnic vascular control during sepsis and endotoxemia. Front Biosci 1997; 2: E72-E92.
16. Kempley S. T., Murdoch E. Splanchnic hemodynamic disturbances in perinatal sepsis. Arch Dis Child Fetal Neonatal Ed 2000; 83: F139-F142.
17. Gonzalez A., Sosenko I. R. S., Chandar J., Hummler H. et al. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Paediatr 1996; 128: 470-478.
18. Salzer H. R., Salzer-Muhar U., Pollak A., Weninger M. Sepsis and indomethacin failure in premature infants with symptomatic patent ductus arteriosus. Lancet 1987; 25: 977.
19. Herson V. C., Krause P. J., Eisenfeld L. I., Pontius L. et al. Indomethacin associated sepsis in very low birth weight infants. Am J Dis Child 1988; 142: 555-558.
20. Morecroft J. A., Spitz L. The role of inflammatory mediators in necrotising enterocolitis. Semin Neonatol 1997; 2: 273-280.
21. Hsueh W., Gonzalez-Crussi F., Arroyave J. L. Sequential release of leukotriens and norepinephrine in rat bowel after platelet activating factor. Gastroenterology 1988; 94: 1412-1418.
22. Hsueh W., Gonzalez-Crussi F., Arroyave J. L. Platelet activating factor induced ischaemic bowel necrosis. An investigation of secondary mediators in its pathogenesis. Am J Pathol 1986; 122: 231-239.
23. Gonzalez-Crussi F., Hsueh W. Experimental role of ischaemic bowel necrosis: the role of platelet-activating factor and endotoxin. Am J Pathol 1983; 112: 127-135.
24. Caplan M. S., Sun X. M., Hseuh W., Hageman J. R. Role of platelet activating factor and tumour necrosis factor alpha in neonatal necrotising enterocolitis. J Paediatr 1990; 116: 960-964.
25. Caplan M. S., Hseuh W., Kelly A., Donovan M. Serum PAF acetylhydrolase increases during neonatal maturation. Prostaglandins 1990; 39: 705-713.
26. MacKendrick W., Hill N., Hseuh W., Caplan M. Increase in plasma platelet activating factor levels in enterally fed preterm infants. Biol Neonate 1993; 64: 89-95.
27. Lucas A., Cole T. J. Breast milk and neonatal necrotising enterocolitis. Lancet 1990; 336: 1519-1523.
28. Furukawa M., Narahara H., Yasuda K., Johnstone J. M. Presence of platelet activating factor acetylhydrolase in milk. J Lipid Res 1993; 34: 1603-1609.
29. Nowicki P. T., Miller C. E., Edwards R. C. Effects of hypoxia and ischaemia on autoregulation in postnatal intestine. Am J Physiol 1991; 261: G152-G157.
30. Hseuh W., Gonzalez-Crussi F., Arroyave J. L. Platelet activating factor: an endogenous mediator for bowel necrosis in endotoxaemia. FASEB J 1987; 1: 403-405.
31. Caplan M. S., Kelly A., Hseuh W. Endotoxin and hypoxia induced intestinal necrosis in rats: the role of platelet activating factor. Paediatr Res 1992; 31: 428-434.
32. Sun X. M., MacKendrick W., Tien J., Huang W., Caplan M. S., Hseuh W. Endogenous bacterial toxins are required for the injurious action of platelet activating factor in rats. Gastroenterology 1995; 109: 83-88.
33. McDonnell M., Wilkinson A. Necrotising enterocolitis-perinatal approach to prevention, early diagnosis and management. Semin Neonatol 1997; 2: 291-296.
34. Mihatsch W. A., von Schoenaich P., Fahnenstich H., Dehne N., Ebbecke H., Plath C., von Stockhausen H. B., Muche R., Franz A., Pohlandt F. The significance of gastric residuals in the early enteral feeding advancement of extremely low birth weight infants. Pediatrics 2002; 109: 457-459.
35. Jadcherla S. R., Kliegman R. M. Studies of feeding intolerance in very low birth weight infants: definition and significance. Pediatrics 2002; 109: 516-517.
36. Brown E. G., Sweet A. Y. Preventing necrotising enterocolitis in neonates. JAMA 1978; 240: 2452-2454.
37. Spritzer R., Koolen A. M., Baerts W. et al. A prolonged decline in the incidence of necrotising enterocolitis after the introduction of a cautious feeding regimen. Acta Paediatr Scand 1988; 77: 909-911.
38. Kamitsuka M. D., Horton M. K., Williams M. A. The incidence of necrotising enterocolitis after introducing standardised feeding schedules for infants between 1250 and 2500 grams and less than 35 weeks of gestation. Paediatrics 2000; 105: 379-384.
39. La Gamma E. F., Browne L. E. Feeding practices for infants weighing less than 1500 grams at birth and the pathogenesis of necrotising enterocolitis. Clin Perinatol 1994; 21: 271-305.
40. Halac E., Halac J., Begue E. F., Casnas J. M., Indiveri D. R., Petit J. F., Figueroa M. J., Olmas J. M., Rodriguez L. A., Obregon R. J. et al. Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial. J Pediatr 1990; 117: 132-138.
41. Precioso A. R., Proenca R. S. M. Necrotizing enterocolitis, pathogenesis and the protector effect of prenatal corticosteroids. Rev Hosp Clin Fac Med S Paulo 2002; 57: 243-248.
42. Donoghue D and the ANZNN. The report of the Australian and New Zealand Neonatal Network, 2000. Sydney: ANZNN; 2002.
43. Schulman R. J., Schanler R. J., Lau C., Heitkemper M., Ou C. N., Smith E. O. Early feeding, antenatal steroids, and human milk decrease intestinal permeability in preterm infants. Pediatr Res 1998; 44: 519-523.
44. Hylander M. A., Strobino D. M., Dhanireddy R. Human milk feeding and infection among very low birth weight infants. Pediatrics 1998; 102: E38.
45. Furman L., Taylor G., Minich B. S., Hack M. The effect of maternal milk on neonatal morbidity of very low birth weight infants. Arch Pediatr Adolesc Med 2003; 157: 66-71.
46. Arnold L. D. The cost effectiveness of using banked donor milk in the neonatal intensive care unit: prevention of necrotizing enterocolitis. Human Lact 2002; 18: 172-177.
47. Caplan M.S., Amer M., Jilling T. The role of human milk in necrotizing enterocolitis. Adv Exp Med Biol 2002; 503: 83-90.
48. Kelleher S. L., Lonnerdal B. Immunological activities associated with milk. Adv Nutr Res 2001; 10: 39-65.
49. Kosloske A. M. Breast milk decreases the risk of neonatal necrotizing enterocolitis. Adv Nutr Res 2001; 10: 123-137.
50. Goldman A. S. Modulation of the gastrointestinal tract of infants by human milk. Interfaces and interactions. An evolutionary perspective. J Nutr 2000; 130: 426S-431S.
51. Falcao M. C. Necrotizing enterocolitis: prevention is the ultimate goal. Rev Hosp Clin Fac Med S Paulo 2002; 57: 199-200.